Abstract:

2-Oxo-3-hydroxy lysergic acid diethylamide (O-H-LSD), a major LSD metabolite, has previously been demonstrated to be a superior marker for identifying LSD use compared with the parent drug, LSD. Specifically, O-H-LSD analyzed using liquid chromatography–mass spectrometry has been reported to be present in urine at concentrations 16 to 43 times greater than LSD. To further support forensic application of this procedure, the specificity of the assay was assessed using compounds that have structural and chemical properties similar to O-H-LSD, common over-the-counter products, prescription drugs and some of their metabolites, and other drugs of abuse. Of the wide range of compounds studied, none were found to interfere with the detection of O-H-LSD or the internal standard 2-oxo-3-hydroxy lysergic acid methyl propylamide. The stability of O-H-LSD was investigated from 0 to 9 days at various temperatures, pH conditions, and exposures to fluorescent light. Additionally, the effect of long-term frozen storage and pH was investigated from 0 to 60 days. There was no significant loss of O-H-LSD under both refrigerated and frozen conditions within the normal human physiological pH range of urine (4.6–8.4). However, significant loss of O-H-LSD was observed in samples prepared at pH 4.6–8.4 and stored at room temperature or higher (24–50°C).

Language: English

Document Type:

Affiliations: 1: Navy Drug Screening Laboratory, P.O. Box 113, Bldg. H-2033, Naval Air Station, Jacksonville, Florida 32212 2: Navy Drug Screening Laboratory, 34425 Farenholt Avenue Suite 40, San Diego, California 92134-7040